Stay updated on Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with site header/navigation, indicating access is blocked rather than showing the study record. This reflects an access-control issue rather than a substantive update to the content.
    Difference
    19%
    Check dated 2026-09-21T22:57:37.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, representing a minor update to the page version. No changes to the displayed study content or details are indicated.
    Difference
    0.0%
    Check dated 2026-08-31T17:40:41.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    A new line '2018 ( U.S. NIH Grant/Contract )' was added to the study's funding information, indicating NIH support for the trial.
    Difference
    0.0%
    Check dated 2026-08-24T16:36:37.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision label updated from Revision: v3.6.4 to Revision: v3.6.5, signaling a new page version. This update appears to be a backend/versioning change rather than a visible content change.
    Difference
    0.0%
    Check dated 2026-08-10T11:54:41.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a newer release of the page or system.
    Difference
    0.0%
    Check dated 2026-07-27T05:56:39.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page build or content.
    Difference
    0.0%
    Check dated 2026-07-05T11:44:36.000Z thumbnail image

Stay in the know with updates to Biomarker Response to Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Response to Pembrolizumab in NSCLC Clinical Trial page.